Evidence map›Paper›PMID 42392980›Full record

ArticleLife science alliance2026

TERT drives liver tumorigenesis beyond telomere elongation.

Laura Braud, Julien Vernerey, Arnaud Guille, Pierre Cordier, Clémence Ginet, Tom Egger, Manuel Bernabe, Dmitri Churikov, Quentin Da Costa, Aïda Meghraoui and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life science alliance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Laura BraudCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France laura.braud@inserm.fr.ORCID https://orcid.org/0000-0002-8958-3817
Julien VernereyCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France.ORCID https://orcid.org/0000-0002-5413-4210
Arnaud GuillePredictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
Pierre CordierCentre de recherche des Cordeliers, Sorbonne université, Inserm, Université Paris Cité, Équipe labellisée par la Ligue Nationale Contre le Cancer, Paris, France.
Clémence GinetAMKbiotech, BIOPARC, Biot, France.
Tom EggerQuantimagin, Montpellier, France.
Manuel BernabeCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France.
Dmitri ChurikovCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France.ORCID https://orcid.org/0000-0003-1127-8852
Quentin Da CostaPredictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.ORCID https://orcid.org/0000-0001-8904-9131
Aïda MeghraouiAMKbiotech, BIOPARC, Biot, France.
Chantal DesdouetsCentre de recherche des Cordeliers, Sorbonne université, Inserm, Université Paris Cité, Équipe labellisée par la Ligue Nationale Contre le Cancer, Paris, France.ORCID https://orcid.org/0000-0002-1955-8915
Li GuDepartment of Laboratory Medicine and Clinical Laboratory Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China.
François BertucciPredictive Oncology Laboratory, Marseille Cancer Research Centre (CRCM), Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.
Christophe LachaudCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University, DNA Interstrand Crosslink Lesions and Blood Disorder Team, Marseille, France.
Vincent GéliCRCM, Inserm, CNRS, Institut Paoli-Calmettes, Aix-Marseille University Marseille, Équipe labellisée par la Ligue Nationale Contre le Cancer, Marseille, France vincent.geli@inserm.fr.ORCID https://orcid.org/0000-0002-4103-7462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We generated two mouse models, p21

Indexed as

CarcinogenesisCarcinoma, HepatocellularLiver NeoplasmsTelomeraseTelomereAnimalsbeta CateninDisease Models, AnimalGene Expression Regulation, NeoplasticHumansLiverMaleMiceMutationTelomere Homeostasisbeta CateninTelomeraseTert protein, mouse

Identifiers

PMID42392980
PMCPMC13329133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.